Articles

Data may lift Lilly’s fortunes in diabetes market-WEB ONLY

Could Eli Lilly be getting some revenge in the diabetes market? The Indianapolis drugmaker released clinical trial data today showing that its long-acting version of Byetta helped patients reduce their blood sugar and weight better than the long-acting insulin Lantus. Lantus, made by France-based Sanofi-Aventis SA, is a drug that stole significant insulin market share […]

Read More

Long-term-care business to help Wishard cover construction debt

To pay for a shiny new downtown hospital, the parent corporation of Wishard Health Services will commit itself to yearly
debt payments 10 times as high as they are now. But Wishard officials have no doubt they can bear the extra load
because of places like Rosewalk Village, a nursing home that sits on the eastern side of Indianapolis.

Read More

Doctors group files complaint against Anthem-WEB ONLY

The Indiana State Medical Association has filed a formal complaint against Anthem Blue Cross and Blue Shield of Indiana for ongoing claims-payment issues. The doctors group, in an announcement today, contends that computer problems at Anthem have yet to be resolved, breaching a 2005 court settlement reached by doctors and Anthem’s parent company, Indianapolis-based WellPoint […]

Read More

Lilly making bid for animal health business-WEB ONLY

Indianapolis-based Eli Lilly and Co. and four of its peers have to submit second bids this week in a scramble to acquire the animal health businesses of two other drugmakers, Merck & Co. Inc. and Schering-Plough Corp. The final decision on who gets what and at what price is expected by the end of July, […]

Read More

BREAKING: FDA gives OK to Lilly’s prasugrel-WEB ONLY

Eli Lilly and Co. finally won approval today from U.S. regulators to sell prasugrel, its highly anticipated blood thinner, according to Bloomberg News. The U.S. Food and Drug Administration approved prasugrel to prevent blood clots when patients come in to receive stents or other coronary devices. The drug will have the trade name Effient. After […]

Read More

Indianapolis benefits firms merge

Two Indianapolis benefits consulting firms have finalized their merger, the companies announced this morning. Terms of the
deal between Benefit Associates Inc. and Benefit Consultants Inc., in the works since March, were not disclosed.

Read More

Local benefits firms complete merger-WEB ONLY

Two Indianapolis benefits consulting firms have finalized their merger, the companies announced this morning.Benefit Associates Inc. and Benefit Consultants Inc. revealed their plans to merge in March. Terms of the deal were not disclosed.The two companies have not selected a common name, and will continue to operate under both names “for the next few months,” […]

Read More

Dems defend pharma in health care debate-WEB ONLY

Health care reform is making for odd bedfellows. The pharmaceutical industry – which for two decades has given twice as much in campaign donations to Republicans as Democrats – organized a panel composed mostly of Democrats on Tuesday in Indianapolis to argue its position on health care reform. Former Democratic House Majority Leader Richard Gephardt […]

Read More

Lilly cancer drug OK’d for new use

Eli Lilly and Co.’s top rising-star drug has been approved by U.S. regulators for a new use, an event that could boost sales of
the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer
for certain patients, Lilly announced today.

Read More

Franklin College sues like-named competitor over marketing push

Franklin College filed a lawsuit today alleging trademark infringement against Ohio-based Franklin
University, which will open a campus in Castleton this fall. The liberal arts college south of Indianapolis
said the newcomer’s marketing blitz has been too close to Franklin College’s own branding.

Read More

College sues like-named competitor-WEB ONLY

The confusion has finally gotten to Franklin College. The liberal arts college south of Indianapolis filed a lawsuit today alleging trademark infringement against Ohio-based Franklin University, which will open a campus in Castleton this fall. Franklin University has run a heavy advertising campaign to mark its entrance into Indianapolis. But Franklin College said the marketing […]

Read More

Franklin College sues like-named competitor-WEB ONLY

The confusion has finally gotten to Franklin College. The liberal arts college south of Indianapolis filed a lawsuit today in federal court in Indianapolis alleging trademark infringement against Ohio-based Franklin University, which will open a campus in Castleton this fall. Franklin University has run a heavy advertising campaign to mark its entrance into Indianapolis. But […]

Read More

Lilly cancer drug approved for new use-WEB ONLY

Eli Lilly and Co.’s top rising-star drug has been OK’d by U.S. regulators for a new use, an event that could boost sales of the medication. Alimta, a lung cancer drug, was approved as a maintenance therapy for non-small cell lung cancer for certain patients, Lilly announced today. The approval by the U.S. Food and […]

Read More

Lilly kicks lobbying into high gear-WEB ONLY

Once again Eli Lilly and Co. is running in the lead pack in dollars spent to bend ears on Capitol Hill. And that was even before the health care reform debate got rolling. Through the first quarter, the Indianapolis-based drugmaker was on pace to break the record amount of lobbying it did last year, when it […]

Read More

FEAR and HOPING in health care-WEB ONLY

Former Mayor Bart Peterson outlines the pitch Eli Lilly will make in D.C. For the first time in 15 years, lawmakers in Washington have plunged into a debate about overhauling the nation’s health care system. New proposals come out every week, with bills filed in Congress running longer than 600 pages and 10-year cost estimates […]

Read More